Levine A - Search Results

1

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.

Justman JE, Benning L, Danoff A, Minkoff H, Levine A, Greenblatt RM, Weber K, Piessens E, Robison E, Anastos K. Justman JE, et al. Among authors: levine a. J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):298-302. doi: 10.1097/00126334-200303010-00009. J Acquir Immune Defic Syndr. 2003. PMID: 12626890 Clinical Trial.

2

Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.

Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ; Women's Interagency HIV Study Collaborative Research Group. Kirstein LM, et al. Among authors: levine a. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):495-503. doi: 10.1097/00126334-200204150-00010. J Acquir Immune Defic Syndr. 2002. PMID: 11981366

3

Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.

Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, Hoover DR. Anastos K, et al. Among authors: levine a. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):383-92. doi: 10.1097/00126334-200404010-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15097155

4

The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women.

Anastos K, Schneider MF, Gange SJ, Minkoff H, Greenblatt RM, Feldman J, Levine A, Delapenha R, Cohen M; Women's Interagency HIV Study Collaborative Group. Anastos K, et al. Among authors: levine a. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):537-44. J Acquir Immune Defic Syndr. 2005. PMID: 16044004

5

Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women.

Cohen MH, Hotton AL, Hershow RC, Levine A, Bacchetti P, Golub ET, Anastos K, Young M, Gustafson D, Weber KM. Cohen MH, et al. Among authors: levine a. J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):538-44. doi: 10.1097/QAI.0000000000000795. J Acquir Immune Defic Syndr. 2015. PMID: 26284531 Free PMC article.

6

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.

Neely MN, Benning L, Xu J, Strickler HD, Greenblatt RM, Minkoff H, Young M, Bremer J, Levine AM, Kovacs A. Neely MN, et al. Among authors: levine am. J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):38-42. doi: 10.1097/01.qai.0000248352.18007.1f. J Acquir Immune Defic Syndr. 2007. PMID: 17106279 Free PMC article.

7

Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study.

Sobieszczyk ME, Hoover DR, Anastos K, Mulligan K, Tan T, Shi Q, Gao W, Hyman C, Cohen MH, Cole SR, Plankey MW, Levine AM, Justman J; Women's Interagency HIV Study. Sobieszczyk ME, et al. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):272-80. doi: 10.1097/QAI.0b013e31817af461. J Acquir Immune Defic Syndr. 2008. PMID: 18545157

8

Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.

Telzak EE, Hershow R, Kalish LA, Hardy WD Jr, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K. Telzak EE, et al. Among authors: levine a. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):513-8. doi: 10.1097/00042560-199812150-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9859966

9

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

Anastos K, Barrón Y, Miotti P, Weiser B, Young M, Hessol N, Greenblatt RM, Cohen M, Augenbraun M, Levine A, Muñoz A; Women's Interagency HIV Study Collaborative Study Group. Anastos K, et al. Among authors: levine a. Arch Intern Med. 2002 Sep 23;162(17):1973-80. doi: 10.1001/archinte.162.17.1973. Arch Intern Med. 2002. PMID: 12230420

10

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.

Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, Gange SJ. Anastos K, et al. Among authors: levine a. Ann Intern Med. 2004 Feb 17;140(4):256-64. doi: 10.7326/0003-4819-140-4-200402170-00007. Ann Intern Med. 2004. PMID: 14970148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,577 results

Search Page